Armis Biopharma Overview
- Year Founded
-
1997
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$14.5M
- Investors
-
1
Armis Biopharma General Information
Description
Developer of non-systemic antimicrobial products intended to protect against resistant pathogens and chemical/biological warfare agents. The company's platform is a proprietary peracid/hydrogen peroxide-based non-systemic antimicrobial agent. It is highly selective and has been independently verified to eliminate a wide range of bacterial, viral, fungal, and toxic agent threats, enabling organizations to provide for a variety of markets, including healthcare, defense, and industrial.
Contact Information
Website
armisbiopharma.comCorporate Office
- 2950 East Harmony Road
- Suite 252
- Fort Collins, CO 80528
- United States
Corporate Office
- 2950 East Harmony Road
- Suite 252
- Fort Collins, CO 80528
- United States
Armis Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 15-Sep-2022 | $14.5M | Completed | Generating Revenue | ||
| 5. Grant | 09-Nov-2020 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 24-Sep-2018 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 17-Nov-2017 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 01-Jan-2017 | $5.5M | $8.7M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 16-Apr-2014 | $3.2M | $3.2M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Armis Biopharma Comparisons
Industry
Financing
Details
Armis Biopharma Competitors (5)
One of Armis Biopharma’s 5 competitors is Virion Therapeutics, a Venture Capital-Backed company based in Philadelphia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Virion Therapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| Arbutus Biopharma | Corporation | Warminster, PA | ||||
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Ecolab | Corporation | Saint Paul, MN | ||||
| GlaxoSmithKline (Consumer Healthcare Business) | Corporate Backed or Acquired | Brentford, United Kingdom |
Armis Biopharma Patents
Armis Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3223608-A1 | Sprayer head having integrated secondary internal liquid reservoir | Pending | 16-Aug-2021 | ||
| US-20230415182-A1 | Sprayer head having integrated secondary internal liquid reservoir | Pending | 16-Aug-2021 | ||
| US-20240173732-A1 | Sprayer head having integrated secondary internal liquid reservoir | Inactive | 16-Aug-2021 | ||
| EP-4387771-A1 | Sprayer head having integrated secondary internal liquid reservoir | Pending | 16-Aug-2021 | ||
| EP-4087691-A1 | Compositions and methods for remediating chemical warfare agent exposure and surface decontamination | Pending | 07-Jan-2020 | B09C1/08 |
Armis Biopharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Armis Biopharma Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Neurological Disorders and Stroke | Government |
Armis Biopharma FAQs
-
When was Armis Biopharma founded?
Armis Biopharma was founded in 1997.
-
Where is Armis Biopharma headquartered?
Armis Biopharma is headquartered in Fort Collins, CO.
-
What is the size of Armis Biopharma?
Armis Biopharma has 10 total employees.
-
What industry is Armis Biopharma in?
Armis Biopharma’s primary industry is Drug Discovery.
-
Is Armis Biopharma a private or public company?
Armis Biopharma is a Private company.
-
What is Armis Biopharma’s current revenue?
The current revenue for Armis Biopharma is .
-
How much funding has Armis Biopharma raised over time?
Armis Biopharma has raised $27.9M.
-
Who are Armis Biopharma’s investors?
National Institutes of Neurological Disorders and Stroke has invested in Armis Biopharma.
-
Who are Armis Biopharma’s competitors?
Virion Therapeutics, Arbutus Biopharma, Intellia Therapeutics, Ecolab, and GlaxoSmithKline (Consumer Healthcare Business) are competitors of Armis Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
